Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Health Wire.
Press releases published on October 7, 2025
Bimergen Energy Announces $200 Million Equity Commitment for Battery Energy Storage Projects
Newport Beach, CA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation [OTCQB: BESS] (“the Company” or “Bimergen”), a developer of utility-scale battery energy storage projects and an independent power provider, announced today that it has …
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data show sustained or deepening …
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
BROOMFIELD, Colo., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help …
Resalis Therapeutics Reports Durable, Fat-Selective Weight Loss with RES-010 in Non-Human Primates at Multiple Scientific and Industry Meetings
Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on its lead candidate RES-010, a first-in-class antisense oligonucleotide targeting microRNA-22 (miR-22). The …
New Data Presented on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2025 World Muscle Society Congress
Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile Consistent efficacy demonstrated across age groups MILAN, Italy, October 07, 2025 – Italfarmaco S.p.A. announced …
Salipro Biotech Strengthens Global IP Portfolio with Two New Japanese Patents
STOCKHOLM, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focused on unlocking “undruggable” membrane protein targets, today announced the issuance of two new patents by the Japanese Patent Office. These patents further …
Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer
Dr Saggese will lead the expansion of the company's clinical trials with lead oncolytic immunotherapy THEO-260 THEO-260, is currently being investigated in patients with platinum-resistant ovarian cancer Oxford UK, October 7, 2025. Theolytics, a clinical- …
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today …
Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate
Former GSK and Sanofi executive, led Cervarix® development and advanced pioneering therapies for rare diseases, decade of experience as venture capitalist Strengthens Bioxodes leadership following encouraging Phase 2a interim data for lead candidate BIOX- …
Bioxodes nomme Philippe Monteyne, un vétéran de l’industrie pharmaceutique, au poste de président et accélère le développement en phase avancée de son candidat médicament innovant dans l’AVC
Ancien dirigeant de GSK et de Sanofi, M. Monteyne a supervisé le développement de Cervarix® et permis l’avancement de plusieurs traitements pionniers dans les maladies rares ; il apporte dix années d’expérience en capital-risque. Cette nomination vient …
Allegro showcases superior shock-absorbing capacity of injectable hydrogel for osteoarthritis at CellMech
Comparative testing against four market-leading hydrogels demonstrates Hydrocelin’s superior shock absorbing capacity Significantly improves the shock-absorbing capacity of pathological equine synovial fluid in mechanical testing Data were presented at …
Carlsbad Dental Care Expands Access to Modern Dentistry with New Patient Special and Financing Options
Carlsbad, CA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Carlsbad Dental Care, a trusted local practice led by Dr. Raymond Ngo, is improving access to high-quality dental care for families across the Carlsbad community with its New Patient Special that combines a …
Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress
Single dose of avigbagene parvec (FLT201) demonstrates sustained clinical benefit and favorable safety up to two years after withdrawal of prior chronic therapy Data underscore potential to set new standard-of-care LONDON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- …